PRESS RELEASE
News
-
-
PRESS RELEASE
HKSTP Reached out to World-class Universities in the US on Talent Nurturing and Sparked Huge Interest in Hong Kong’s I&T Ecosystem
Hong Kong Science and Technology Parks Corporation (HKSTP) recently embarked on a US West Coast Tour to explore collaboration opportunities with NVIDIA, Google, Linkedin, and other tech leaders through its Innovation Mixer events. The tour aimed to connect the US and Hong Kong innovation communities, showcasing the booming opportunities in Asia. With a focus on talent initiatives and partnerships, HKSTP engaged with prestigious academic institutions and market-leading tech enterprises during the tour, highlighting Hong Kong's growing innovation and technology ecosystem. The tour signifies HKSTP's commitment to fostering global innovation and technology collaborations. -
PRESS RELEASE
Partners Group further strengthens its Real Estate business with three leadership appointments
Partners Group, a leading private markets firm, has announced the addition of three senior leaders to its Real Estate business. The new appointments bring extensive experience in platforms and operationally intensive sectors, complementing and strengthening the firm's global real estate team. The move reflects Partners Group's commitment to scaling its real estate business and its strategic vision for meeting thematic growth trends and navigating industry disruption. -
PRESS RELEASE
G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose against upper respiratory infections
G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose (2-DG) against upper respiratory infections and secures over EUR 6 million for Phase II clinical trial. The intranasal administration of 2-DG was found to be safe, well tolerated, and did not lead to any serious adverse events (SAEs). The compound targets rhinoviruses and coronaviruses, offering potential broad-spectrum antiviral treatment against respiratory tract infections. The successful financing round includes a EUR 4 million Series A funding led by xista science ventures (xsv), with additional commitment from the Life Sciences Programme of the Austrian Research Promotion Agency (FFG). G.ST Antivirals, a spin-off from the Medical University of Vienna, is on track to advance its innovative drug against colds and other viral infections, with the Phase II clinical trial set to commence in the first half of 2024. -
PRESS RELEASE
Troy Minerals Recently Completed Drone Magnetic Survey Identifies Ree Trend at Lac Jacques
Troy Minerals Inc. announces the results of the 2023 drone magnetics survey on the Lac Jacques rare earth element (REE) property, featuring a significant magnetic anomaly associated with magnetite content in syenitic intrusive rocks. The company will commence further work to identify drill targets for the winter 2024 drill program using the data collected, including magnetics, soil geochemistry, and geology. The press release also provides information about the company's other mineral exploration projects. -
-
PRESS RELEASE
Original-Research: q.beyond AG (von NuWays AG): BUY
This press release provides updated research on q.beyond AG, with an emphasis on the company's performance, financial outlook, and strategic priorities for 2024. The report highlights the ongoing restructuring process and macro-headwinds that have impacted the company's operating performance, outlines the FY '23 guidance, and presents expectations for the preliminary FY figures and FY '24 guidance. It also discusses the company's 2025 Strategy and its implications for sales growth, FCF generation, and EBITDA. The research remains cautiously optimistic about the company's prospects and recommends a BUY rating. The press release includes contact information for further inquiries and the full analysis download link. -
PRESS RELEASE
Original-Research: MLP SE (von NuWays AG): BUY
This research report from NuWays AG provides a strong recommendation to BUY MLP SE stocks, with a price target of €11.00 over the next 12 months. The report highlights MLP's strong diversification across business segments, solid profitability projection, tailwinds from new interest rate trends, potential for highly profitable performance fees, and the unlikely downside from the real estate business. The report emphasizes the unjustified valuation of MLP shares, trading at historically low multiples, and recommends adding MLP to NuWays' Alpha List 2024. -
PRESS RELEASE
Semperit starts its 200th anniversary year
Semperit Group is celebrating its 200th anniversary in 2024, highlighting its centuries-long tradition and path to a successful future under the motto '200 Years of Semperit – Experience for Tomorrow'. The company looks back on its history, presents current success stories and emphasizes its commitment to continued success. For more information, visit www.200.semperitgroup.com. -
PRESS RELEASE
SBF takes next growth step and completes consolidation of AMS Software & Elektronik
SBF AG takes a significant growth step by completing the consolidation of AMS Software & Elektronik, strengthening its position as a leading specialist for innovative solutions in areas such as rolling stock, lighting, electromechanics, and sensor technology. The consolidation will lead to a diversified growth with the three divisions 'Rolling Stock', 'Public and Industrial Lighting', and 'Sensor Technology and Electromechanics'. The company expects a significant revenue growth in 2024 as a result of this consolidation.
